Bio-Works Technologies AB (publ) (FRA:1BD)

Bio-Works Technologies AB Statistics

Total Valuation

FRA:1BD has a market cap or net worth of EUR 29.14 million. The enterprise value is 25.87 million.

Market Cap	29.14M
Enterprise Value	25.87M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	99.42M
Shares Outstanding	n/a
Shares Change (YoY)	+65.69%
Shares Change (QoQ)	+31.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	59.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.00
PB Ratio	6.41
P/TBV Ratio	6.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.36
EV / Sales	4.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.57

Financial Position

The company has a current ratio of 3.20

Current Ratio	3.20
Quick Ratio	2.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-90.77

Financial Efficiency

Return on equity (ROE) is -32.51% and return on invested capital (ROIC) is -23.35%.

Return on Equity (ROE)	-32.51%
Return on Assets (ROA)	-17.77%
Return on Invested Capital (ROIC)	-23.35%
Return on Capital Employed (ROCE)	-35.60%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	201,084
Profits Per Employee	-48,582
Employee Count	29
Asset Turnover	1.02
Inventory Turnover	1.14

Taxes

Income Tax	-177,044
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +207.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+207.69%
50-Day Moving Average	0.24
200-Day Moving Average	0.20
Relative Strength Index (RSI)	68.81
Average Volume (20 Days)	1,056

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:1BD had revenue of EUR 5.83 million and -1.41 million in losses. Loss per share was -0.02.

Revenue	5.83M
Gross Profit	4.47M
Operating Income	-1.62M
Pretax Income	-1.59M
Net Income	-1.41M
EBITDA	-1.57M
EBIT	-1.62M
Loss Per Share	-0.02

Balance Sheet

The company has 3.23 million in cash and n/a in debt, with a net cash position of 3.23 million.

Cash & Cash Equivalents	3.23M
Total Debt	n/a
Net Cash	3.23M
Net Cash Per Share	n/a
Equity (Book Value)	4.55M
Book Value Per Share	0.05
Working Capital	4.39M

Cash Flow

In the last 12 months, operating cash flow was -1.74 million and capital expenditures -37,331, giving a free cash flow of -1.78 million.

Operating Cash Flow	-1.74M
Capital Expenditures	-37,331
Free Cash Flow	-1.78M
FCF Per Share	n/a

Margins

Gross margin is 76.71%, with operating and profit margins of -27.76% and -24.16%.

Gross Margin	76.71%
Operating Margin	-27.76%
Pretax Margin	-27.20%
Profit Margin	-24.16%
EBITDA Margin	-26.95%
EBIT Margin	-27.76%
FCF Margin	n/a

Dividends & Yields

FRA:1BD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.69%
Shareholder Yield	-65.69%
Earnings Yield	-4.83%
FCF Yield	-6.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:1BD has an Altman Z-Score of -1.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.72
Piotroski F-Score	1